Kopran Ltd Share Price
(KOPRAN)
₹202.62▲2.33%
as on 11:24AM, 24 Apr 2025
Kopran Performance
Day's Low
Day's High
₹197.1Day's Price Range₹205.6752 Week's Low
52 Week's High
₹15552-Week Price Range₹369.7
| Returns % | |
| 1 Month Return | + 4.04 % |
| 3 Month Return | -0.54 % |
| 1 Year Return | -24.63 % |
| Market Stats | |
| Previous Close | ₹198.00 |
| Open | ₹202.62 |
| Volume | 1.46L |
| Upper Circuit | ₹237.60 |
| Lower Circuit | ₹158.40 |
| Market Cap | ₹956.05Cr |
Kopran Fundamentals
P/E Ratio
20.1
PEG Ratio
13.77
Market Cap
₹956.05 Cr
P/B Ratio
2.99
EPS
10.57
Dividend Yield
1.16
Sector
Pharmaceuticals
ROE
8.53
Mutual Fund Holdings of Kopran
| Funds | Holdings | Prev. 5M |
|---|---|---|
 Bandhan BSE Healthcare Index Fund Direct Growth | 0.04% |
Key events for Kopran Ltd
Kopran Ltd Shows Strong Growth and Upcoming Merger - 16 Apr, 2025
Kopran Ltd has demonstrated significant sales and profit growth, with a 578% increase in share price since April 2020. The company plans to merge with Kopran Laboratories Limited, enhancing its market position.Madhuri Kela Increases Stake in Kopran Amid Challenges - 10 Apr, 2025
Madhuri Kela raised her stake in Kopran Ltd to 1.46%, signaling confidence despite the stock's 37% decline over the past year. The company is merging with Kopran Laboratories to optimize operations. Recent performance shows a 4% gain in March 2025, but the stock remains below its 52-week peak.Kopran Ltd Announces Strategic Merger to Enhance Market Position - 23 Mar, 2025
Kopran Ltd. plans a strategic merger with Kopran Laboratories Ltd. to enter the growing Indian diagnostics market, aiming for increased profitability and market presence. This merger is expected to be EPS accretive and enhance shareholder value.Kopran Ltd Surges After Merger Approval - 21 Mar, 2025
Kopran Ltd's stock jumped 6.5% following the board's approval of a merger with Kopran Laboratories Limited. The merger aims to enhance operational efficiency under the Companies Act, 2013. Despite a decline in net profits, Kopran Ltd reported a revenue increase in Q3 FY25, indicating potential growth post-merger.
Insights on Kopran Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTFII Holding Up
Foreign Institutions have increased holdings from 0.86% to 1.12% in Mar 2025 quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 7.38 Cr → 10.4 Cr (in ₹), with an average increase of 29.0% per quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 142.06 Cr → 166.41 Cr (in ₹), with an average increase of 7.6% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Divis Laboratories Ltd has given 56.9% return, outperforming this stock by 80.4%
- NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 137.6% return, outperforming this stock by 163.6%
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 54.67% to 54.45% in Mar 2025 quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 44.45% to 44.42% in Mar 2025 quarter
- NEGATIVE IMPACT
Price Dip
In the last 7 days, KOPRAN stock has moved down by -2.9%
Kopran Financials
Kopran Index Inclusions
Kopran Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 44.42% | 0.00 | |
| Foreign Institutions | 1.12% | 0.00 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 54.45% | 0.00 | |
| Others | 0% | 0.00 |
Kopran Key Indicators
Kopran Valuation
Kopran in the last 5 years
Lowest (3.00x)
March 24, 2020
Today (20.10x)
April 23, 2025
Industry (53.87x)
April 23, 2025
Highest (53.33x)
September 5, 2023
Kopran Earnings and Dividends
Kopran Ltd Earnings Results
Kopran Ltd’s net profit fell -34.14% since last year same period to ₹10.40Cr in the Q3 2024-2025. On a quarterly growth basis, Kopran Ltd has generated 40.92% jump in its net profits since last 3-months.
Read More about Earnings ResultsKopran Ltd Dividends May,2024
In the quarter ending March 2024, Kopran Ltd has declared dividend of ₹3 - translating a dividend yield of 3.03%.
Read More about Dividends
Kopran Technicals Summary
Bearish
Neutral
Bullish
Kopran Ltd is currently in a Bullish trading position according to technical analysis indicators.
Kopran Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹956.05 Cr | 119.68% | 0.53 | ₹50 Cr | ₹614 Cr | |
| NA | ₹11.15 Cr | 66.72% | 0.50 | NA | NA | |
| NA | ₹2,987.44 Cr | 39.26% | 0.53 | ₹96 Cr | ₹1,690 Cr | |
| NA | ₹520.52 Cr | 260.56% | 0.73 | ₹7 Cr | ₹1 Cr | |
| NA | ₹157.93 Cr | 105.19% | 0.69 | NA | NA |
About Kopran
Revenue: ₹166.24Cr as on December 2024 (Q4 24)
Net Profit: ₹10.40Cr as on December 2024 (Q4 24)
Listing date: 01 Dec, 1994
Chairperson Name: Susheel Somani
| Organisation | Kopran |
| Headquarters | |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
FAQs on Kopran Ltd
What is Kopran Ltd price today?
Kopran Ltd share price today stands at ₹202.62, Open: ₹202.62, Previous Close: ₹198, High: ₹205.67, Low: ₹197.1, 52 Week High: ₹369.7, 52 Week Low: ₹155.
How to Buy Kopran Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Kopran Ltd shares
What are today's traded volumes of Kopran Ltd?
Today's traded volume of Kopran Ltd(KOPRAN) is 1.46L.
What is today's market capitalisation of Kopran Ltd?
Today's market capitalisation of Kopran Ltd(KOPRAN) is ₹956.05Cr.
What is the 52 Week High and Low Range of Kopran Ltd?
How much percentage Kopran Ltd is down from its 52 Week High?
Kopran Ltd (KOPRAN) share price is ₹202.62. It is down -45.19% from its 52 Week High price of ₹369.7
How much percentage Kopran Ltd is up from its 52 Week low?
Kopran Ltd (KOPRAN) share price is ₹202.62. It is up 30.72% from its 52 Week Low price of ₹155